Topic

Combination therapies Steady

655 applications whose title mentions it. Its share of new filings over the last two years is 1% above the four years before.

Allowance rate

42%

−33 pts vs the USPTO 495 decided

Months to first action

19.3 mo

+0.7 vs the USPTO

Applications

655.0

in the record

Allowed

208.0

287 abandoned

Filings by year

How often the topic was filed

The most recent years are still filling in.

Where it is examined

Domains and art units

CPC subclasses

A61K497 apps

C07K67 apps

A61P58 apps

G01N10 apps

C12N6 apps

G16H5 apps

Art units

162976 apps

164265 apps

164353 apps

OPAP50 apps

162744 apps

162844 apps

Examiners

Who examines it, and how it fares with each

Docket Central51 apps

n/a

Shirley V Gembeh26 apps

52%

Sheela Jitendra Huff25 apps

56%

Tori Strong11 apps

55%

Nelson B Moseley II10 apps

50%

Umamaheswari Ramachandran10 apps

60%

Kevin E Weddington10 apps

50%

Sarah Abdoalatif Alsomairy8 apps

60%

Bars show the share of decided applications that were allowed.

Unlock the examiners behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who files it

Companies and institutions

Mirati Therapeutics, Inc.27 apps

78%

Janssen Biotech, Inc.23 apps

60%

IPSEN BIOPHARM LIMITED22 apps

39%

The General Hospital Corporation20 apps

47%

NOVARTIS AG17 apps

38%

Genentech, Inc.16 apps

77%

Bars show the share of decided applications that were allowed.

Unlock the filers behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents

FOLEY HOAG, LLP (General)36 apps

33%

HENRY HADAD24 apps

71%

COOLEY LLP23 apps

35%

McNeill PLLC/Ipsen22 apps

56%

HAMILTON, BROOK, SMITH & REYNOLDS, P.C.18 apps

46%

K&L Gates - Novartis18 apps

33%

Bars show the share of decided applications that were allowed.

Unlock the firms behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Applications

Recent applications on this topic

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19881579	COMBINATION THERAPIES COMPRISING PEPTIDE-DRUG CONJUGATES TARGETING SORTILIN	2026-10-01	Pending	0	0	n/a
19622742	COMBINATION THERAPIES AND METHODS FOR MYELIN GROWTH AND TREATMENT OF AGE-RELATED HE…	2026-09-10	Pending	0	0	n/a
19620242	COMBINATION THERAPIES FOR THE TREATMENT OF HR+/HER2- METASTATIC OR LOCALLY ADVANCED…	2026-09-01	Pending	0	0	n/a
15681182	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15329077	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15634271	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15188524	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15155826	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15957896	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15617173	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock every application on this topic, with its timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in